4A85.00 Drug-induced liver hypersensitivity disease International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2026-01 Drug-induced liver hypersensitivity disease is a relatively rare condition, but can have serious consequences for the individual patient, public health, regulatory agencies and the pharmaceutical industry. It is characterised by elevation in serum alanine-aminotransferase (ALT), conjugated bilirubin, or combined bilirubin, ALT and alkaline phosphatase (AP) levels > 2 times the upper limit of normal (ULN) and the most frequent related drugs are halothane, tienilic acid, dihydralazine, diclofenac, and carbamazepine.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Associated with - multiple selections are allowed [select] PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use PL01 Complementary or traditional medicines associated with injury or harm in therapeutic use PL0Z Substances associated with injury or harm in therapeutic use, unspecified PL01.0 Complementary or traditional medicines associated with injury or harm in therapeutic use, Herbal Preparations or Formulas PL01.1 Complementary or traditional medicines associated with injury or harm in therapeutic use, Dietary Supplements, Vitamins or Minerals PL01.2 Complementary or traditional medicines associated with injury or harm in therapeutic use, Complementary or Traditional Medicines, not elsewhere classified PL01.Y Other specified complementary or traditional medicines associated with injury or harm in therapeutic use PL01.Z Complementary or traditional medicines associated with injury or harm in therapeutic use, unspecified PL13 Mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.0 Overdose of substance, as mode of injury or harm PL13.1 Underdosing, as mode of injury or harm PL13.2 Drug-related injury or harm in the context of correct administration or dosage, as mode of injury or harm PL13.3 Incorrect substance, as mode of injury or harm PL13.5 Incorrect administration of drug or medicament, as mode of injury PL13.6 Medication or substance that is known to be an allergen, as mode of injury or harm PL13.7 Medication or substance that is known to be contraindicated for the patient, as mode of injury or harm PL13.8 Expired or deteriorated medication or substance, as mode of injury or harm PL13.9 Drug or substance interactions, as mode of injury or harm PL13.A Inappropriate stoppage or discontinuation of drug, as mode of injury or harm PL13.Y Other specified mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.Z Mode of injury or harm associated with exposure to a drug, medicament or biological substance, unspecified PL13.50 Incorrect route of drug or medicament, as mode of injury PL13.51 Incorrect rate of drug or medicament, as mode of injury PL13.52 Incorrect timing of drug or medicament, as mode of injury PL13.53 Incorrect duration of drug or medicament, as mode of injury PL13.5Y Other specified incorrect administration of drug or medicament, as mode of injury PL13.5Z Incorrect administration of drug or medicament, as mode of injury, unspecified
synonyms Drug-induced liver hypersensitivity disease Immune-mediated DILI - [drug-induced liver injury] medicament-induced liver hypersensitivity disease
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Aimee - AI-powered coding assistant
Would you like Aimee - AI to help you with this?